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CASE REPORT
Streptococcus anginosus, a member of the
Streptococcus milleri group,1–3 is known as a normal
flora of the oral cavity and a pathogen of thoracic
infection.4–6 The S. milleri group has often been
isolated with oral anaerobes in pulmonary infec-
tion.7 Synergies between the S. milleri group and
oral anaerobes have been suspected though not
yet confirmed. Moderate to severe comorbidities
are important risk factors for S. milleri infection.8
Many S. anginosus-related thoracic infections, such
as empyema and lung abscesses, have been re-
ported.5,6 However, our review found no reports
of disseminated infection of S. anginosus identi-
fied from both urine and empyema. We report 
a case of disseminated S. anginosus infection,
which was successfully treated with imipenem
and open drainage.
Case Report
A 52-year-old man had right thigh sarcoma with
lung and bone metastasis diagnosed in March
2004. On June 1, 2004, he was admitted for third-
course chemotherapy with ifosphamide 5.4 g (3 g/
m2) and etoposide 130 mg (75 mg/m2). The pa-
tient had not undergone any dental procedure re-
cently. Four days after chemotherapy, he developed
spiking fever, productive cough and progressive
dyspnea. No frequency, urgency or dysuria was ob-
served. Hemogram showed leukopenia, 210 white
blood cells/mm3 (normal, 4000–11,000/mm3),
anemia (hemoglobin, 7.4 g/dL; normal, 12.3–
t18.3 g/dL) and a low-borderline platelet coun
(118,000/mm3, normal, 120,000–320,000/mm3).
Metabolic acidosis (arterial blood gas: pH, 7.375;
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PCO2, 26.2 mmHg; PO2, 99 mmHg; HCO3−, 15.5
mmol/L; under a non-rebreathing mask), hy-
perbilirubinemia (total bilirubin, 82.7 μmol/L;
normal, 3.4–17 μmol/L), hyperammonemia (96
μmol/L; normal, 9–33 μmol/L) and elevated
C-reactive protein (22.4 mg/dL; normal, <0.8 mg/
dL) were also noted. He was treated for febrile
neutropenia and nosocomial pneumonia with
intravenous administration of cefepime (2 g/12
hr). However, profound septic shock and hypox-
emic respiratory failure developed and he was in-
tubated and transferred to the intensive care unit
(ICU). Chest X-ray showed a cavitatory mass over
the right upper lobe (RUL), multilobar consolida-
tion and right loculated pleural effusion (Figure 1).
In the ICU, the patient was in a semicomatose
state. Vital signs included temperature of 37.4°C,
pulse rate of 140 beats/minute, respiratory rate
of 30 breaths/minute and blood pressure of
100/60 mmHg under the administration of dop-
amine 25 μg/kg/minute. Physical examination
showed dry skin turgor, icteric sclera and pale
conjunctiva, decreased breathing sounds with
coarse crackles over the right lower lung field
r and bronchial sounds over the right uppe
lung field. Other physical findings were unre-
markable. Follow-up chest radiography showed
progression of multiple lobar consolidation 
xand development of right hydropneumothora
(Figure 2). Thoracocentesis of right pleural effu-
sion yielded pus-like fluid with a pungent odor.
Gram stain of the pleural effusion showed
polymicrobial infection, which included numer-
ous Gram-positive cocci in chains, Gram-negative
bacilli and yeast. Tube thoracostomy was per-
formed immediately, and air and pus were drained
continuously. Antibiotics were then shifted to
imipenem (500 mg every 6 hours) for mixed flora
infection and better penetration. Four days later,
the pleural effusion culture yielded group F
Streptococcus, Fusobacterium necrophorum and Lacto-
bacillus species, but the sputum culture yielded
only Candida albicans. Urine culture yielded viri-
fdans group streptococci with a colony count o
t1000 colonies/mL, although urinalysis did no
disclose pyuria or hematuria despite the patient’s
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iF gure 1. h h d f b d lC est X-ray on t e ay o  intu ation an  centra
line insertion shows a mass lesion over the right upper
lung, multiple consolidations over the right lower lung and
left lung, with loculated pleural effusion over the right
lower lung.
iF gure 2. d f b h dOne ay a ter intu ation, new-onset y ropneu-
mothorax is apparent over the right lower lung with con-
solidation over bilateral lung fields.
neutropenic status. However, no pathogen was
isolated from blood culture.
Chest computed tomography showed a huge
mass with central necrosis over the RUL, a com-
munication between the right main bronchus,
right pleural cavity and right pneumothorax
(Figure 3). Bronchoscopic study showed rupture
of the right main bronchus that was 2 cm away
from the carina. One-lung ventilation with left
bronchial intubation was performed to improve
persistent air leakage of the right pneumothorax
and to avoid draining of massive necrotic tissue
of the RUL tumor into the left bronchus. Nine
days after intubation, tracheostomy was performed
with the endotracheal tube directed to the left
main bronchus. Right lung air leakage subsided
soon after one-lung ventilation, but pus persist-
ently drained from the right chest tube. Intermit-
tent low grade fever and leukocytosis persisted
under antibiotics, which impeded the progress of
the weaning program. Open drainage from the
right lower chest was performed. The patient be-
came afebrile soon after open drainage and was
smoothly weaned from the ventilator after 45 days.
The isolates from pleural effusion and urine
samples were identified as group F Streptococcus
(Oxoid, Unipath Limited, Basingstoke, England).
The isolates grew well and had pinpoint colo-
nies of beta-hemolysis on trypticase soy agar 
supplemented with 5% sheep blood. They were
catalase-negative and Gram-positive cocci. Group
F antigen reactions of the isolates were positive.
The two isolates were identified as S. intermedius
based on three commercial identification kits,
including the API STREP, Phoenix System (Beckon
KDickson, Cockeysville, MD, USA) and VITE
(99% identification) (bioMérieux Vitek, Inc.,
Hazelwood, MO, USA). However, the isolates
showed negative reactions for α-glucosidase 
r and hyaluronidase and positive reactions fo
β-N-acetylgalactosaminidase and β-N-acetylglu-
cosaminidase. This profile was in accordance
with the identification of S. anginosus. The 16S
rRNA partial sequencing (1322 bp) analysis
using the primer pair 8FPL (5-AGAGTTTGAT-
CCTGGCTCAG-3) and 1492 (5-GGTTACCTT-
GTTACGACTT-3) identified S. anginosus with
ridentification of 99% (accession numbe
AY691540).9,10 Antimicrobial susceptibility was
performed using the E test (PDM Episilometer; AB
Biodisk, Solna, Sweden), performed on Mueller–
Hinton agar supplemented with 5% sheep blood
agar (BBL Microbiology Systems, Cockeysville,
MD, USA) in 5% CO2 and ambient air at 35°C.
The minimum inhibitory concentration (MIC)
was 0.12 μg/mL for penicillin, 0.25 μg/mL for ce-
fotaxime, 0.25 μg/mL for cefepime and 0.12 μg/
mL for imipenem.
Discussion
Viridans group streptococci is comprised of a
heterogeneous group of facultatively anaerobic,
Gram-positive cocci that does not produce catalase
or coagulase, and rarely produces beta-hemolysis
on sheep blood agar.11 S. anginosus, S. constellatus
and S. intermedius are commonly referred to as the
S. milleri group (SMG).1,2,6,11 SMG strains are nor-
ymal flora of the oral cavity and genitourinar
tract.4 They are known for their association with
purulent infection, which usually occurs after local
disruption of the mucosal barrier, such as ulcera-
tion, perforation, inflammation and surgery.2,5,6
In addition, SMG has often been associated with
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iF gure 3. Contrast-enhanced chest computed tomography
on the 6th day of intensive care unit admission shows a
mass over the right upper lung with central necrosis.
Communication of the right main bronchus to the right
pleural cavity was noted at the level of bifurcation (arrow).
Left pleural effusion with left upper lobe atelectasis is also
shown.
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mixed infection, especially with anaerobic infec-
tion.7 Strains of S. anginosus are mainly beta-
hemolytic and frequently present Lancefield group
F antigens, although some strains may be of group
A, C, or G, or are nongroupable.6,11 Previous
research in the literature have demonstrated an
association of S. milleri species with major surgery,
surgical procedure involving the respiratory or 
digestive tract and nosocomial infection.12
In a previous study, isolation of these organ-
isms from empyema and lung abscesses was
associated with a high mortality rate in those
with malignant disease.5 Previous studies have
also reported identification of SMG species in
0.7–40% of patients with culture-positive tho-
racic empyema.7,13 In Chen et al’s13 report, SMG
accounted for 69.8% of thoracic empyema of viri-
dans Streptococcus over a 10-year peroid. Only one
isolate of S. anginosus was identified in this re-
port. SMG was an important pathogen of thoracic
empyema, but S. anginosus was not a common iso-
late. Although the isolation of S. anginosus from
blood has been reported many times, isolation of
S. anginosus from both urine and empyema has
never been reported so far. In this case, S. anginosus
was identified by sequencing analysis of 16S rRNA.
The rRNA sequences of both isolates from urine
and pleural effusion in our patient had a high de-
gree (>99%) of similarity with the sequences of 
S. anginosus,9,10 which confirms that the isolates
from both empyema and urine were of the same
strain. By sequencing 16S rRNA, Streptococcus
species infection was clearly identified, confirming
disseminated infection of S. anginosus.
Confirmation of disseminated S. anginosus in-
fection by cultures of thoracic empyema and urine
and 16S rRNA gene sequence has not been previ-
ously reported. Hematogenous spread was the
possible mechanism responsible for disseminated
infection. Factors associated with disseminated
infection in this case included immunocom-
promise, necrosis and cavitations of pulmonary
sarcoma, aspiration of oral secretion and con-
comitant anaerobic infection.
Strains of group F Streptococcus were demon-
strated to be susceptible to penicillin G.4 However,
Farber et al14 showed that 9% of the group F
streptococcal strains were highly resistant to
penicillin G (MICs>4μg/mL). Furthermore, Fujiki
et al8 yreported that the number of intermediatel
or completely resistant strains against penicillin
G was 33.3%. Clinically, infection caused by group
F streptococci responds well to penicillin G and
cephalosporins.11,15 In this case, the MIC for peni-
cillin was 0.12 μg/mL. Possible rexplanations fo
the higher MIC in this case include nosocomial in-
fection and previous use of antibiotics, which
tcould have led to the selection of more resistan
strains. Thoracostomy is often required for com-
plete resolution of empyema. Our patient was
treated with imipenem and concomitant tube
thoracostomy. As a result, S. anginosus twas no
isolated from subsequent cultures.
In summary, this is an uncommon docu-
mented case of disseminated S. anginosus infec-
ytion including thoracic empyema and urinar
tract infection. The identification was confirmed
by nucleotide sequencing of the 16S rRNA gene.
Factors associated with the disseminated in-
fection include an immunocompromised state,
necrosis and cavitations of pulmonary sarcoma,
aspiration and concomitant anaerobes infec-
tion. Treatment with imipenem led to a good
recovery.
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